Ben Garber

Benjamin J. Garber is a Director at Crosstree, a boutique investment bank focused exclusively on health sciences M&A and financing advisory. Crosstree says Garber has more than a dozen years of M&A and healthcare operating experience and has advised healthcare technology and tech-enabled services companies serving payer, provider, and life sciences markets on M&A and growth capital transactions.

Before joining Crosstree, Garber led the Healthcare practice at 7 Mile Advisors, an information-technology-focused investment bank. 7 Mile announced his hiring on July 1, 2019, naming him Vice President and head of its Healthcare Delivery & Provider Services practice, with a mandate to expand 7 Mile’s footprint in Pittsburgh and the Northeast.

Earlier, Garber was Senior Director, Corporate Development & Innovation at MedExpress Urgent Care, an Optum / UnitedHealth Group subsidiary. In that role, 7 Mile said he was responsible for MedExpress acquisitions and joint ventures, relationships with health systems, physician groups, insurers, and business partners, and innovation initiatives across MedExpress, Optum, and UnitedHealthcare.

Garber spent five years at Grouse Ridge Capital, described by 7 Mile as a lower-middle-market private equity firm, where he sourced and executed investments in heavy industrials, robotic automation, and technology. 7 Mile reported that he managed four control acquisitions, seven minority investments, two de novo startups, and raised more than $40 million of outside equity financing. He holds an MBA from Carnegie Mellon University’s Tepper School of Business and a B.S. in Plant and Soil Science from the University of Vermont.

• Focuses on healthcare technology and tech-enabled services serving payer, provider, and life sciences end markets.
• Crosstree frames the opportunity around healthcare enterprises’ increasing reliance on specialized advisory and tech-services partners to remain competitive and improve outcomes, a trend the firm says is driving strong investment interest.
• Within healthcare technology, Crosstree’s focus areas include pharma technology, software as a medical device, health information systems, data science, interoperability, real-world data, and reporting.
• At 7 Mile, Garber emphasized outpatient-care fragmentation as a platform-building opportunity: “As the hospital becomes disintegrated and pushed out into a variety of outpatient facilities, that creates a greater fragmentation in the provider landscape, as well as the opportunity for roll-up platforms in each one of those sectors.”
• Earlier at Grouse Ridge Capital, his investment work covered heavy industrials, robotic automation, and technology, including control acquisitions, minority investments, startups, and distressed manufacturing turnarounds.
• Public sources do not disclose a current personal angel check size.